JPS62103088A - Production of 4,5,6,7-tetrahydrothieno(3,2-c)-pyridine or salt thereof - Google Patents
Production of 4,5,6,7-tetrahydrothieno(3,2-c)-pyridine or salt thereofInfo
- Publication number
- JPS62103088A JPS62103088A JP24238785A JP24238785A JPS62103088A JP S62103088 A JPS62103088 A JP S62103088A JP 24238785 A JP24238785 A JP 24238785A JP 24238785 A JP24238785 A JP 24238785A JP S62103088 A JPS62103088 A JP S62103088A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- reaction
- salt
- reacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、抗炎症活性、血管拡張活性、血小板凝集活性
等を有する薬物として知られる5 −(2−クロロベン
ジル) −4,5,6,7−チトラヒトロチエノ(3,
2−C)ピリジン又はその塩を製造する際の中間体原料
物質として有効に使用される下記式で示される4、5,
6.7−チトラヒドロチエノ(3,2−C〕ピリジン又
はその塩の新規な製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides 5-(2-chlorobenzyl)-4,5,6,7-titrahydrothieno( 3,
2-C) 4, 5, represented by the following formula, which is effectively used as an intermediate raw material when producing pyridine or its salt.
The present invention relates to a novel method for producing 6.7-titrahydrothieno(3,2-C]pyridine or a salt thereof.
従来の技術
従来、抗炎症活性、血管拡張活性、血小板凝集活性等を
有する薬物として知られる下記式(3)で示される5−
(2−クロロベンジル) −4,5,6゜7−チトラヒ
ドロチエノ(3,2−C)ピリジン又はその塩の製造方
法として、下記(a)〜(c)に示す方法等が提案され
ている。BACKGROUND OF THE INVENTION Conventionally, 5- shown by the following formula (3) is known as a drug having anti-inflammatory activity, vasodilatory activity, platelet aggregation activity, etc.
(2-Chlorobenzyl) -4,5,6゜7-titrahydrothieno(3,2-C)pyridine or its salts have been proposed as methods shown in (a) to (c) below. There is.
(a)5−(2−りooベンジル)−チェノ(3、2−
C:1−ピリジニウムクロライドを還元する方法(%公
昭52−31357号公報、下記反応式囚参照)。(a) 5-(2-rioobenzyl)-cheno(3,2-
C: A method for reducing 1-pyridinium chloride (see Publication No. 31357/1983, reaction formula below).
t
(b)N−(2−クロロベンジル)−2−(2−チェニ
ル)エチルアミンにホルムアルデヒドを加え、これを塩
酸水溶液中で加熱して環化させる方法(特開昭51−1
01996号公報、下記反応式(B)参照)。t (b) A method of adding formaldehyde to N-(2-chlorobenzyl)-2-(2-thenyl)ethylamine and heating it in an aqueous hydrochloric acid solution to cyclize it (JP-A-51-1
No. 01996, see reaction formula (B) below).
(a) 4 、5 、6 、7−チトラヒドロチエノ
(3,2−C)ピリジンに2−クロロベンジルクロライ
ドを反応させる方法(Eur 、 J 、Med 、
Chem、 −Chemica Terapeutic
aなお、その他特開昭53−95994.同55−33
469、同54−19994、同51−48692、同
52−36691.同52−91891、同53−97
60、同59−27895、同52−8793、同54
−9298.特公昭52−31357号公報、C,A、
91.56977v、 C,A、94.47305J
等に記載の方法が知られている。(a) Method of reacting 4,5,6,7-titrahydrothieno(3,2-C)pyridine with 2-chlorobenzyl chloride (Eur, J, Med,
Chem, -Chemica Terapeutic
aIn addition, other Japanese Patent Application Laid-open No. 53-95994. 55-33
469, 54-19994, 51-48692, 52-36691. 52-91891, 53-97
60, 59-27895, 52-8793, 54
-9298. Special Publication No. 52-31357, C, A,
91.56977v, C, A, 94.47305J
The method described in et al. is known.
このような(3)式の化合物又はその塩を得る方法にお
いて、反応式(C)に示すように式(2)で示される4
、5,6.7−チトラヒドロチエノ(3,2−C〕ピリ
ジンは(3)式の化合物又はその塩の合成中間体として
有用であるが、従来この(21式の化合物を得る方法と
しては下記反応式の)
(Eur、J、Med、 Chem、−Chemiea
Tarapeutica 9 (45)483〜4
86.1974)
に示す方法が知られている。In the method for obtaining such a compound of formula (3) or a salt thereof, 4 represented by formula (2) as shown in reaction formula (C)
, 5,6.7-titrahydrothieno(3,2-C]pyridine is useful as a synthetic intermediate for the compound of formula (3) or its salt, but the conventional method for obtaining the compound of formula (21) is (Eur, J, Med, Chem, -Chemiea) of the following reaction formula
Tarapeutica 9 (45) 483-4
86.1974) is known.
発明が解決しようとする問題点
しかしながら、この反応式(ロ)Kよる式(2)の化合
物の製造方法は、その合成に際し反応段階数が長く、操
作が煩わしいため、(2)式の化合物を合成するのにコ
ストが高くつき、ひいては゛(3)式の目的化合物が経
済的に製造されないという欠点がある。Problems to be Solved by the Invention However, the method for producing the compound of formula (2) according to reaction formula (b)K requires a long number of reaction steps during its synthesis, and the operation is cumbersome. There is a disadvantage that the synthesis cost is high and the target compound of formula (3) cannot be produced economically.
従りて、上記方法は工業的に不利であシ、このため従来
よシ工業的規模において満足すべき(2)式の化合物又
はその塩の製造方法の開発が要望されていた。Therefore, the above method is industrially disadvantageous, and there has been a demand for the development of a method for producing the compound of formula (2) or a salt thereof that is satisfactory on an industrial scale.
問題点を解決するための手段
本発明者らは、上記事情に鑑み、前記(2)式の化合物
を収率よくしかも簡単に、更に安価に得る方法につき鋭
意検討を行なった結果、下記式(1)で示される2−(
2−チェニル)−エチルアミンとホルムアルデヒドとを
反応させた後、反応生成物であるイミンに塩化水素を反
応させてこのイミンを環化させることによシ、(2)式
の化合物又はその塩が高い収率で得られること、このよ
うにして得られた(2)式の化合物を中間体原料物質と
して経由し、(3)式の化合物又はその塩を合成するこ
とにより 、(3)式の化合物又はその塩が安価に得ら
れることを知見し、本発明をなすに至ったものである。Means for Solving the Problems In view of the above circumstances, the present inventors have conducted intensive studies on a method for obtaining the compound of the formula (2) in a high yield, easily, and at a lower cost.As a result, the following formula ( 1) 2-(
After reacting 2-chenyl)-ethylamine with formaldehyde, the reaction product imine is reacted with hydrogen chloride to cyclize the imine, thereby producing a compound of formula (2) or a salt thereof. By using the thus obtained compound of formula (2) as an intermediate raw material and synthesizing the compound of formula (3) or its salt, the compound of formula (3) can be obtained with a high yield. The present invention was based on the discovery that a salt thereof can be obtained at low cost.
従って、本発明は、下記式(1)
で示される2−(2−チェニル)−エチルアミンとホル
ムアルデヒドとを反応させた後、反応生成物に塩化水素
を反応させることによシこの反応生成物を環化させて、
下記式(2)
で示される4、5,6.7−チトラヒドロチエノ[3,
2−C)ピリジン又はその塩を得ることを特徴とする4
、5゜6.7−チトラヒドロチエノ(3,2−C)ピリ
ジン又はその塩の製造方法を提供するものである(下記
反応式(ト))参照)。Therefore, the present invention involves reacting 2-(2-thenyl)-ethylamine represented by the following formula (1) with formaldehyde, and then reacting the reaction product with hydrogen chloride. Cyclize it,
4,5,6,7-titrahydrothieno[3,
2-C) 4 characterized by obtaining pyridine or a salt thereof
, 5°6.7-titrahydrothieno(3,2-C)pyridine or a salt thereof (see reaction formula (g) below).
以下、本発明につき更に詳しく説明する。The present invention will be explained in more detail below.
本発明においては(2)式の化合物又はその塩を得る場
合に、まず前記(1)式の化合物にホルムアルデヒドを
反応させた後、反応生成物であるイミンに塩化水素を反
応させるものである。この場合、その反応条件は種々選
択されるが、(1)式の化合物1モルに対してホルムア
ルデヒドを1〜1.5モル、特に1,1モル程度反応さ
せることが好ましい。また、反応は水性媒体中で行なわ
せることが好適で、例えば(1)式の化合物にホルムア
ルデヒド水溶iを加えることにより良好に反応させるこ
とができる。In the present invention, when obtaining the compound of formula (2) or a salt thereof, first the compound of formula (1) is reacted with formaldehyde, and then the reaction product imine is reacted with hydrogen chloride. In this case, various reaction conditions may be selected, but it is preferable to react 1 to 1.5 mol, particularly about 1.1 mol, of formaldehyde per 1 mol of the compound of formula (1). Further, the reaction is preferably carried out in an aqueous medium, and for example, the reaction can be carried out favorably by adding aqueous formaldehyde i to the compound of formula (1).
更に、生成イミンは完全な無水状態にした後精製するこ
となく塩化水素と反応させることが好ましい。例えば反
応液にエーテルを加えてエーテル層を分離し、これを無
水硫酸マグネシウム等で乾燥した後、減圧下で濃縮乾固
することによシ、良好に完全無水の粗製イミンを得るこ
とができる。Furthermore, it is preferable that the produced imine is made completely anhydrous and then reacted with hydrogen chloride without purification. For example, a completely anhydrous crude imine can be obtained by adding ether to the reaction solution, separating the ether layer, drying it over anhydrous magnesium sulfate, etc., and then concentrating to dryness under reduced pressure.
また、イミンに塩化水素を反応させる場合、イミン1モ
ルに対して塩化水素、好ましくは乾燥塩化水素を2〜2
46モル、特に2.2モル程度反応させることか好適で
ある。更に、反応はジメチルホルムアミド等の中性極性
溶媒中で行なわせることが適轟で、例えば乾燥塩化水素
のツメチルホルムアミド溶液にイミンのジメチルホルム
アミド溶液を加えることによシ、良好に閉環反応を行な
わせて(2)式の化合物を塩の形で得ることができるも
のである。In addition, when reacting imine with hydrogen chloride, hydrogen chloride, preferably dry hydrogen chloride, is added at 2 to 2 to 1 mole of imine.
It is preferable to react about 46 moles, particularly about 2.2 moles. Furthermore, the reaction is suitably carried out in a neutral polar solvent such as dimethylformamide; for example, by adding a solution of imine in dimethylformamide to a solution of dry hydrogen chloride in dimethylformamide, the ring-closing reaction can be carried out well. Thus, the compound of formula (2) can be obtained in the form of a salt.
ここで、本発明方法の出発原料である(1)式の化合物
は、例えば下記方法によって得ることができる。Here, the compound of formula (1), which is the starting material for the method of the present invention, can be obtained, for example, by the following method.
即ち、ジメチルスルホキシドとテトラヒドロ2ランとの
混合溶媒中で2−クロロメチルチオフェンにシアン化ナ
トリウムを反応させ、2−シアノメチルチオフェンを得
た後、これを無水エーテル中において塩化アルミニウム
を触媒として水素化アルミニウムリチウムで還元するか
(J、C,S。That is, 2-chloromethylthiophene was reacted with sodium cyanide in a mixed solvent of dimethyl sulfoxide and tetrahydro2rane to obtain 2-cyanomethylthiophene, which was then hydrogenated in anhydrous ether using aluminum chloride as a catalyst. Reduce with aluminum lithium (J, C, S.
Parkfn l + 138 + 19766下記反
応式ケ)参照)、2−チオフェンアルデヒドにニトロメ
タンを縮合させ、2−(β−二トロビニル)チオフェン
を得、更にこれを無水エーテル中で水素化アルミニウム
リチウムで還元する( J、O,C,15、807(1
950) :某誌74.1301(1954);下記反
応式(G)参照)ことによシ(1)式の化合物を得る方
法であシ、これにより (1)式の化合物が収率良く得
られるものである。Parkfn l + 138 + 19766 (refer to reaction formula q) below), 2-thiophene aldehyde is condensed with nitromethane to obtain 2-(β-nitrovinyl)thiophene, which is further reduced with lithium aluminum hydride in anhydrous ether. (J, O, C, 15, 807 (1
950): Certain Journal 74.1301 (1954); see reaction formula (G) below) is a method for obtaining a compound of formula (1), whereby a compound of formula (1) can be obtained in good yield. It is something that can be done.
また、本発明方法によって得られた(2)式の化合物は
、(3)式の化合物又はその塩を合成する際の原料物質
として好適に使用できる。Furthermore, the compound of formula (2) obtained by the method of the present invention can be suitably used as a raw material when synthesizing the compound of formula (3) or a salt thereof.
の化合物又はその塩を良好に得ることができる(下記反
応式(ロ)参照)。The compound or its salt can be obtained satisfactorily (see reaction formula (b) below).
ここで、上記反応(ロ)における反応条件は必ずしも制
限されないが、(2)式の化合物1モルに対して2−ク
ロロベンズアルデヒドを1〜1.5モル、特に1.1モ
ル程度、及びギ酸を2〜2.5モル、特に2.2モル程
度反応させることが好適である。また、反応は90〜1
00℃において2〜8時間、特に4時間程度、二酸化炭
素が発生しなくなるまで行なわせることが好ましい。Here, the reaction conditions in the above reaction (b) are not necessarily limited, but 1 to 1.5 mol, particularly about 1.1 mol of 2-chlorobenzaldehyde and formic acid are added to 1 mol of the compound of formula (2). It is preferable to react about 2 to 2.5 moles, particularly about 2.2 moles. Also, the reaction is 90-1
It is preferable to carry out the reaction at 00° C. for 2 to 8 hours, particularly about 4 hours, until no carbon dioxide is generated.
なお、このようにして得られた(3)式の化合物は、常
法によシ薬学的に受は入れ可能な無機又は有機の酸の塩
に変えることができる。The compound of formula (3) thus obtained can be converted into a pharmaceutically acceptable inorganic or organic acid salt by a conventional method.
シ、高収率で、かつ安価に(3)式の化合物又はその塩
を製造できる。Second, the compound of formula (3) or its salt can be produced in high yield and at low cost.
即ち、上述したように従来は(3)式の化合物を得る方
法としては、反応式囚、 (B) 、 (C)等の方法
が採用されていたものであるが、(4)及び(C)の方
法は目的物の収率が低く、また(B)の方法は中間体の
合成に際しアルカリ金属或いはグリニャル試薬を使用す
るため操作が煩わしく、しかも2−クロロベンジルアミ
ンのような高価な原料を多量に使用しなければならない
という問題があった。従って、この点の解決が求められ
ていたものであるが、反応式(6)の方法によれば(3
)式の化合物又はその塩を収率よく簡単にしかも経済的
に製造し得るものである。That is, as mentioned above, conventional methods for obtaining the compound of formula (3) include reaction formula, (B), (C), etc., but methods (4) and (C) have been adopted. The method (B) has a low yield of the target product, and the method (B) uses an alkali metal or a Grignard reagent in the synthesis of the intermediate, making the operation complicated and requiring expensive raw materials such as 2-chlorobenzylamine. There was a problem that a large amount had to be used. Therefore, there was a need to solve this problem, but according to the method of reaction formula (6), (3
) or a salt thereof can be produced simply and economically with good yield.
発明の詳細
な説明したように、本発明製造方法によれば、上記(3
)式の5−(2−クロロベンジル) −4,5,6,7
−チトラヒドロチエノ(3,2−C〕ピリジン又はその
塩を製造する際の中間体原料物質として有効に使用され
る上記(2)式の4.5,6.7−チトラヒドロチエノ
[:3.2−C〕ピリジン又はその塩を収率良く安価に
得ることができる。As described in detail of the invention, according to the manufacturing method of the present invention, the above (3)
) of the formula 5-(2-chlorobenzyl) -4,5,6,7
-Titrahydrothieno[:3 .2-C] Pyridine or its salt can be obtained in good yield and at low cost.
以下、実施例及び参考例によυ本発明を具体的に示す。Hereinafter, the present invention will be specifically illustrated by Examples and Reference Examples.
(1)式の2−(2−チェニル)エチルアミン4.70
gに35%ホルムアルデヒド水溶液3.5gを室温で加
えて反応させる。この場合、反応液は発熱し、数分間で
イミンが生成される。反応終了後、反応液にエーテル5
QmA!を加え、エーテル層を分離し、これを無水硫酸
マグネシウムで乾燥してから減圧下で濃縮乾固し、反応
中間体である粗製のイミン4.689を得る。2-(2-chenyl)ethylamine of formula (1) 4.70
3.5 g of a 35% formaldehyde aqueous solution was added to the mixture at room temperature and allowed to react. In this case, the reaction solution generates heat and imine is produced within several minutes. After the reaction is complete, add ether 5 to the reaction solution.
QmA! is added, the ether layer is separated, dried over anhydrous magnesium sulfate, and concentrated to dryness under reduced pressure to obtain crude imine 4.689, which is a reaction intermediate.
次に、ジメチルホルムアミド17m/に乾燥塩化水素を
イミンに対して2.2倍モル溶解した溶液中に王妃イミ
ンのジメチルホルムアミド5rlLl溶液を撹拌しなが
ら室温で滴下する。反応液は発熱し、しばらくして結晶
が析出する。そのまま3時間攪拌を続け、得られた結晶
を戸数してアセトンで洗浄した後、乾燥して(2)式の
4.5.6.7−チトラヒドロチエノ(3,2−C)ピ
リジンの塩酸塩4.609を得た(mp222〜225
℃、収率70チ)。Next, a solution of the queen imine in dimethylformamide (5rlLl) was added dropwise at room temperature with stirring into a solution prepared by dissolving dry hydrogen chloride in 17 m/m of dimethylformamide in a molar ratio of 2.2 times the mole of the imine. The reaction solution generates heat and crystals precipitate after a while. Stirring was continued for 3 hours, and the obtained crystals were washed several times with acetone and dried to obtain hydrochloric acid of 4.5.6.7-titrahydrothieno(3,2-C)pyridine of formula (2). Salt 4.609 was obtained (mp222-225
°C, yield 70 cm).
得られた化合物のIRスペクトル及びNMRスペクトル
を別途合成した標準品の4.5,6.7−チトラヒドロ
チエノ(3,2−C)ピリジン塩酸塩の同スペクトルデ
ータとそれぞれ比較したところ、両者は完全に一致した
。When the IR spectrum and NMR spectrum of the obtained compound were compared with the same spectrum data of separately synthesized standard product 4.5,6.7-titrahydrothieno(3,2-C)pyridine hydrochloride, it was found that both It was a perfect match.
〔参考例1〕
実施例に従って得られた(2)式の化合物(フリーの塩
基)2.90gに2−クロロベンズアルデヒド3.21
9 ((2)式の化合物に対して1.1倍モル)及びギ
酸2.11g((21式の化合物に対して2.2倍モル
)を添加し、攪拌しながら90〜100℃に加熱して4
時間反応させる。[Reference Example 1] 3.21 g of 2-chlorobenzaldehyde was added to 2.90 g of the compound of formula (2) (free base) obtained according to the example.
9 (1.1 times the mole relative to the compound of formula (2)) and 2.11 g of formic acid (2.2 times the mole relative to the compound of formula 21) were added, and heated to 90 to 100°C while stirring. and 4
Allow time to react.
次いで、反応液を冷却し、この中に水30m1及び苛性
ソーダ水溶液を加えて塩基性とした後、エーテルで抽出
する。エーテル層を水洗し、無水硫酸マグネシウムで乾
燥した後、減圧下に濃縮して5、509の油状物を得る
。この油状物を無水エーテルに溶解し、この中に乾燥塩
化水素ガスを導入して析出した結晶を戸数した後、エタ
ノールより再結晶して(3)式の5−(2−クロロベン
ジル)−4,5,6,7−チトラヒドロチエノ(3,2
−C)ピリジンの塩酸塩4.55gを得た(mp203
〜205℃、収率73%)。Next, the reaction solution is cooled, 30 ml of water and an aqueous solution of caustic soda are added thereto to make it basic, and then extracted with ether. The ether layer is washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to obtain 5,509 as an oil. This oil was dissolved in anhydrous ether, and dry hydrogen chloride gas was introduced into the solution to separate the precipitated crystals, which were then recrystallized from ethanol to form 5-(2-chlorobenzyl)-4 of formula (3). ,5,6,7-titrahydrothieno(3,2
-C) 4.55 g of pyridine hydrochloride was obtained (mp203
~205°C, yield 73%).
〔参考例2〕
実施例に従って得られた(2)式の化合物(フリー〇塩
基)2.sogに2−クロロベンズアルデヒド3、79
9 ((2)式の化合物に対して1.5倍モル)及びギ
酸2.0717 ((2)式の化合物に対して2.5倍
モル)を添加し、攪拌しながら90〜1001:に加熱
して4時間反応させる。[Reference Example 2] Compound of formula (2) (free 〇 base) obtained according to the example 2. 2-chlorobenzaldehyde 3,79 to sog
9 (1.5 times the mole relative to the compound of formula (2)) and formic acid 2.0717 (2.5 times the mole relative to the compound of formula (2)) were added, and the mixture was heated to 90 to 1001:1 with stirring. Heat and react for 4 hours.
その後、参考例1と同様に処理して(3)式の化合物の
塩酸塩350gを得た(mp203〜205℃、収率6
5%)。Thereafter, treatment was carried out in the same manner as in Reference Example 1 to obtain 350 g of the hydrochloride of the compound of formula (3) (mp 203-205°C, yield 6
5%).
〔参考例3〕
実施例に従って得られた(2)式の化合物(フリーの塩
基>2.sogに2−クロロベンズアルデヒド2.78
9 ((2)式の化合物に対して1.1倍モル)及びギ
酸1.82.9((2)式の化合物に対して′2.2倍
モル)を添加し、攪拌しながら90〜100℃に加熱し
て8時間反応させる。[Reference Example 3] Compound of formula (2) obtained according to Example (free base>2.sog to 2-chlorobenzaldehyde 2.78
9 (1.1 times mole relative to the compound of formula (2)) and formic acid 1.82.9 times ('2.2 times mole relative to the compound of formula (2)) were added, and while stirring, the Heat to 100°C and react for 8 hours.
その後、参考例1と同様に処理し【(3)式の化合物の
塩酸塩3.2411を得た(mp203〜205℃、収
率60チ)。Thereafter, it was treated in the same manner as in Reference Example 1 to obtain 3.2411 hydrochloride of the compound of formula (3) (mp 203-205°C, yield 60%).
なお、参考例1〜3で得られた化合物のIRス被クりル
及びNMRスペクトルを別途合成した標準品の5−(2
−クロロベンジル) −4,5,6,7−チトラヒドロ
チエノ[:3.2−C]ピリジンの同スペクトルデータ
とそれぞれ比較したところ、両者は完全に一致した。ま
た、参考例1〜3で得られた化合物のマススペクトルは
263 (MW−HCl)であった。In addition, the IR spectrum and NMR spectra of the compounds obtained in Reference Examples 1 to 3 were obtained using the separately synthesized standard product 5-(2
-Chlorobenzyl) -4,5,6,7-titrahydrothieno[:3.2-C]pyridine When compared with the same spectrum data, the two completely matched. Moreover, the mass spectra of the compounds obtained in Reference Examples 1 to 3 were 263 (MW-HCl).
Claims (1)
ムアルデヒドとを反応させた後、反応生成物に塩化水素
を反応させることによりこの反応生成物を環化させて、
下記式(2) ▲数式、化学式、表等があります▼・・・(2) で示される4,5,6,7−テトラヒドロチエノ〔3,
2−C〕ピリジン又はその塩を得ることを特徴とする4
,5,6,7−テトラヒドロチエノ〔3,2−C〕ピリ
ジン又はその塩の製造方法。[Claims] 1. After reacting 2-(2-thienyl)-ethylamine represented by the following formula (1) ▲Mathematical formulas, chemical formulas, tables, etc.▼...(1) with formaldehyde, The reaction product is cyclized by reacting the reaction product with hydrogen chloride,
4,5,6,7-tetrahydrothieno[3,
2-C] 4 characterized by obtaining pyridine or a salt thereof
, 5,6,7-tetrahydrothieno[3,2-C]pyridine or a salt thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24238785A JPS62103088A (en) | 1985-10-28 | 1985-10-28 | Production of 4,5,6,7-tetrahydrothieno(3,2-c)-pyridine or salt thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24238785A JPS62103088A (en) | 1985-10-28 | 1985-10-28 | Production of 4,5,6,7-tetrahydrothieno(3,2-c)-pyridine or salt thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62103088A true JPS62103088A (en) | 1987-05-13 |
Family
ID=17088400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP24238785A Pending JPS62103088A (en) | 1985-10-28 | 1985-10-28 | Production of 4,5,6,7-tetrahydrothieno(3,2-c)-pyridine or salt thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62103088A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01319485A (en) * | 1988-05-10 | 1989-12-25 | Sanofi Sa | Reduction of 2-(2-nitrovinyl) thiophene and production of thieno (3, 2-c)pyridine derivative |
US11819056B2 (en) | 2017-01-31 | 2023-11-21 | Altria Client Services Llc | Method of making device with aligning element and consumables |
-
1985
- 1985-10-28 JP JP24238785A patent/JPS62103088A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01319485A (en) * | 1988-05-10 | 1989-12-25 | Sanofi Sa | Reduction of 2-(2-nitrovinyl) thiophene and production of thieno (3, 2-c)pyridine derivative |
US11819056B2 (en) | 2017-01-31 | 2023-11-21 | Altria Client Services Llc | Method of making device with aligning element and consumables |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000063334A (en) | Novel intermediate for the production of enyne derivatives and its production method | |
CN106146518A (en) | A kind of bruton's tyrosine kinase inhibitor intermediate and preparation method thereof | |
CN108314658A (en) | A kind of preparation method of Duo substituted oxazoles derivative | |
JPS62103088A (en) | Production of 4,5,6,7-tetrahydrothieno(3,2-c)-pyridine or salt thereof | |
US7109353B2 (en) | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl | |
JP2007308510A (en) | Derivative of 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyl chloride, its production method, and its use as synthetic intermediate | |
JPS62103087A (en) | Production of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine or salt thereof | |
JPH0641463B2 (en) | Method for producing thiotetronic acid | |
JPS607632B2 (en) | Method for producing thieno(3,2-C)pyridine and its derivatives | |
JP4615861B2 (en) | Production of chirally pure α-amino acids and N-sulfonyl α-amino acids | |
KR940003296B1 (en) | Process for the preparation of ranitidine or acid addition salts thereof | |
KR102713340B1 (en) | Method for producing pyrrolo[1,2-a]quinoline using a cascade reaction of cycloaddition reaction and ring contraction reaction | |
CN110452201B (en) | Synthetic method of benzofuran heterocyclic sulfonyl chloride | |
JPH07215935A (en) | N-trichloroacetyl-2-oxyindole-1-carboxamide | |
WO2006070387A1 (en) | PROCESS FOR PREPARING 5,6-DIHYDRO-4-(S)-(ETHYLAMINO)-6-(S) METHYL-4H-THIENO[2,3b]THIOPYRAN-2-SULPHONAMIDE-7,7-DIOXIDE HCI | |
JPS6261966A (en) | Propionamidine derivatives and manufacture | |
CN119264091A (en) | Synthesis method of 1, 5-disubstituted-3-oxabicyclo [3.1.1] heptane | |
KR920005828B1 (en) | Process for preparing salt of 2-(2-aminomethyl)-thiomethyl-5-dimethyl amino methylfuran | |
JPS59130832A (en) | 4-halogeno-2-chloro-3-phenylcrotonaldehyde | |
JPS62286989A (en) | Thiophene ring substituted alpha-(alkylaminopropionyl)thiophene derivative | |
RU2161152C2 (en) | Method of preparing 2-thiobarbiturc acid | |
CN111606923A (en) | A kind of synthetic method of racemic clopidogrel | |
JPS5852995B2 (en) | Method for producing furfural derivatives | |
JPS58194856A (en) | Novel 2-azetidinone derivative | |
JPS5927883A (en) | Preparation of 4-oxo-4,5,6,7-tetrahydrobenzofuran |